RA Capital Healthcare Reports a $100 Million $CDTX Purchase

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 Cidara Therapeutics $CDTX – RA Capital Healthcare Fund filed a Form 4 for $100 million.

That’s not a trade – it’s a statement.

RA is one of biotech’s sharpest players, and this kind of size is the ultimate tell, especially after the stock has doubled in 2025. 

📌 Kymera Therapeutics $KYMR – Julian Baker just filed a $28.84 million Form 4.

When Baker Bros start writing checks this big, it usually isn’t for fun.

A monster-sized vote of confidence in the biotech space for a stock completing a multi-year base deserves attention.

Here’s The Hot Corner, with data from June 30, 2025:

Click the table to enlarge it.

📌 PVH Corp $PVH – CEO Stefan Larsson put down $1 million for an open-market buy.

Textbook leadership buy in a retail name that’s been fighting the tape. Big enough to matter, and the message is clear. 

📌 Lionsgate Studios $LION – Steven Mnuchin is back with another Form 4, this time for $458,000.

He’s not done building the position in this newly spun studio name. Always notable when a power player keeps adding to his stake.